In Vitro Toxicology Testing Market to Exceed $20.97 Billion by 2031 as Non-Animal Testing & AI Adoption Accelerate - Analysis by Product, Toxicity Endpoints & Type, Technology ...

Featuring Thermo Fisher Scientific, Agilent Technologies, Merck, Eurofins Scientific, Charles River Labs and Other Key Players In Vitro Toxicology Testing Market In Vitro Toxicology Testing Market ...

Black coral shapes influence how microscopic cilia move food and oxygen

An international research team led by scientists from the Max Planck Institute for Marine Microbiology in Bremen and the ...
Tech Times

Ozempic Beats Steroids Against Brain TB Inflammation in Multi-Model Study

Tuberculosis meningitis treatment may be approaching a turning point: a Cincinnati Children’s-led study in Nature Communications finds semaglutide — the diabetes drug sold as Ozempic — outperforms ...

VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced its first commercial sales in ...
Technology Networks

Patient-Derived Organoids: A Powerful Tool in Precision Oncology

Patient-derived organoids contribute to precision medicine by enabling direct drug testing on a patient’s tumor. These models ...
Drug Target Review

Vitronectin protein identified as key driver of lung scarring

Researchers from UTS and Monash University have identified vitronectin as a key protein driving abnormal lung scarring in ...

VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue ...
Tech Times

Gene Editing at Scale: ARPA-H Awards $160M to Mass-Produce Rare Disease Cures

ARPA-H gene editing program THRIVE awards $160 million to seven research teams tasked with building scalable base-editing platforms for rare pediatric genetic diseases — covering liver, blood, brain, ...
The Next Web

A startup just 3D-printed kidney and liver tissue in space, a first

Auxilium says it bioprinted kidney and liver tissue on the ISS, a first. The near-term payoff is drug-testing organoids, not transplant organs.

Creative Biolabs Announces Expert-Led Webinar on Engineered Human 3D Brain Models for Neurodegenerative Disease Research

Creative Biolabs is proud to announce an upcoming industry webinar on engineered human 3D brain tissues for neurodegenerative disease modeling.
autoevolution

Tesla's 4680 Cells Installed in the Model Y LR RWD Variants Are Five Years Behind Competition

Tesla hasn't improved much on the performance of its 4680 cells, which it now uses in some Model Y variants, including Long Range models built at Giga Berlin. The switch was made quietly, leading to a ...
autoevolution

China-Made Tesla Model 3 RWD Exported to Canada Likely Features Superior LFP Cells From Sunwoda

The Tesla Model 3 Premium RWD introduced in Canada is likely powered by new LFP cells produced by Sunwoda. These feature superior characteristics compared to previous CATL cells, including a 4C ...